DAVID JOHNSON: Open Payments
NPI 1851008544 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,571 in 46 payments from 13 companies in 2025. Trend: 2023 $2,998 · 2024 $1,269 · 2025 $1,571
Food & beverage: $1,558Education: $13
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $338 |
| Otsuka America Pharmaceutical, Inc. | 7 | $301 |
| Neos Therapeutics, LP | 1 | $167 |
| Vanda Pharmaceuticals Inc. | 7 | $148 |
| Supernus Pharmaceuticals, Inc. | 5 | $116 |
| Janssen Pharmaceuticals, Inc | 3 | $103 |
| Corium, LLC | 7 | $102 |
| Lundbeck LLC | 3 | $90 |
| Almatica Pharma LLC | 3 | $64 |
| ABBVIE INC. | 2 | $55 |
Products named: REXULTI, LYBALVI, EXXUA, FANAPT, ABILIFY ASIMTUFII, ARISTADA, Qelbree, Azstarys.
Industry payments across NY — which companies pay providers there.
